What Does OWKIN Do?

Total employees471
HeadquartersParis
Founded2016

Owkin is a French-American AI biotechnology company that specializes in applying artificial intelligence and federated learning to drug discovery, drug development, and diagnostics. Their mission is to connect the global healthcare ecosystem through a privacy-preserving, collaborative research platform. By analyzing vast amounts of patient data from leading academic medical centers and pharmaceutical companies, Owkin aims to identify novel drug targets, predict treatment efficacy, develop advanced diagnostic tools, and ultimately accelerate the development of new therapies for critical diseases like cancer and cardiovascular conditions.

Where Is OWKIN's Headquarters?

HQ Function

Serves as the central hub for global operations, strategic leadership, core research and development in AI and federated learning, and coordination of international collaborations.

Notable Features:

Modern office space located in a prestigious district of Paris, designed to foster innovation and collaboration among its diverse teams of scientists, engineers, and medical experts.

Work Culture:

Characterized by a highly innovative, research-intensive, and collaborative environment. Employees (Owkinites) are mission-driven, focusing on leveraging cutting-edge AI to make a significant impact on patient care. The culture is international and values scientific rigor.

HQ Significance:

The Paris headquarters is the primary node for Owkin's pioneering work in AI for healthcare and symbolizes its strong French origins combined with its global ambitions in the biotechnology sector. It's central to their European operations and research partnerships.

Values Reflected in HQ: The headquarters' environment aims to reflect Owkin's core values of innovation, scientific excellence, collaboration, patient-centricity, and responsible AI.

Location:

Owkin supports its global operations through its headquarters in Paris and key offices in New York, London, Boston, and Nantes. Its functions, including AI research, data science, business development, and partnership management, are distributed across these strategic locations to effectively collaborate with a worldwide network of academic medical centers, research institutions, and pharmaceutical companies. Owkin's federated learning model allows for secure, collaborative research across international borders, enabling a truly global impact on drug discovery and patient care.

Street Address:

12 Rue de Presbourg

City:

Paris

State/Province:

Île-de-France

Country:

France

Where Else Does OWKIN Operate Around the World?

New York, NY, USA

Address: 60 East 42nd Street, Suite 4600, New York, NY 10165

To strengthen presence in the major US biotech and pharma ecosystem, facilitating partnerships and access to data networks.

London, UK

Address: The Hickman, 2 Whitechapel Rd, London E1 1EW

Leverages London's position as a leading center for medical research and AI innovation to expand Owkin's federated learning network.

Boston, MA, USA

Address: 1 Broadway, Cambridge, MA 02142 (Kendall Square)

To tap into the dense ecosystem of biotech companies, research institutions, and talent in the Greater Boston area.

Nantes, France

Address: 6 Rue Rose Dieng-Kuntz, 44300 Nantes

To access a strong local tech talent pool and support Owkin's core technology development initiatives in France.

Buying Intent Signals for OWKIN

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Who's Leading OWKIN? Meet the Executive Team

As of April 2025, OWKIN' leadership includes:

Thomas Clozel, M.D. - Co-founder & Chief Executive Officer
Gilles Wainrib, PhD - Co-founder & Chief Scientific Officer
Alban de La Sablière - Chief Operating Officer
Anna Huyghues Despointes - Chief Strategy Officer
Meriem Sefta, PhD - Chief Diagnostics Officer
Jean-Frédéric Petit-Nivard - Chief People Officer
Vassili Soumelis, MD, PhD - Chief Medical Officer

Who's Investing in OWKIN?

OWKIN has been backed by several prominent investors over the years, including:

Sanofi
Bristol Myers Squibb (BMS)
Mubadala Capital
Bpifrance (Large Venture fund)
GV (Google Ventures)
Fidelity Management & Research Company LLC
Cathay Innovation
MACSF

What Leadership Changes Has OWKIN Seen Recently?

Hire0
Exits0

Publicly announced C-suite executive changes at Owkin have been limited in the immediate past 12 months (approx. May 2023 - May 2024). The company has focused on strengthening its scientific advisory board and continues to build out its leadership team as it scales. Information on specific C-level hires or exits is not widely publicized.

What Technology (Tech Stack) Is Used byOWKIN?

Discover the tools OWKIN uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

OWKIN Email Formats and Examples

Owkin commonly uses the 'first.last' email format for its employees. Other variations might exist but this is a widely observed pattern.

[first].[last]@owkin.com

Format

thomas.clozel@owkin.com

Example

90%

Success rate

What's the Latest News About OWKIN?

Sanofi Press ReleaseApril 24, 2024

Owkin news title: Sanofi expands partnership with Owkin to discover and develop new therapies for autoimmune diseases

Sanofi and Owkin announced an expansion of their existing partnership in immunology to include programs in autoimmune diseases. This multi-year collaboration aims to leverage Owkin’s AI capabilities to identify new therapeutic targets and enhance clinical trial design for these conditions, building on their previous successes in oncology....more

Owkin NewsroomNovember 16, 2023

Owkin news title: Owkin's AI Diagnostic RlapsRisk BC Receives CE Mark for Predicting Relapse in Early Breast Cancer Patients

Owkin announced that its AI-driven diagnostic solution, RlapsRisk BC, has received CE-IVD marking in Europe. This tool is designed to predict the risk of relapse in patients with early-stage breast cancer by analyzing digital pathology slides, aiding clinicians in personalizing treatment strategies....more

Owkin NewsroomFebruary 27, 2024

Owkin news title: Owkin strengthens its Strategic Advisory Board with world-leading cancer and AI experts

Owkin announced the appointment of Professor Charles Swanton and Professor John Marioni to its Strategic Advisory Board (SAB). These leading experts in oncology, genomics, and computational biology will provide strategic guidance to enhance Owkin's research and development efforts in AI-driven drug discovery and diagnostics....more

Highperformr's free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including OWKIN, are just a search away.